Watervein Partners is a venture-formation/creator venture capital. We select biotech researchers with foresight and creativity from the university, research institute, and enterprise network; we commit to them from startup process so as to develop into topnotch business. While maintaining partial control of the firmfs side, our investing method is thoroughly hands-on. We lead the firm to a high-profit exit including IPO and M&A with a high probability.
Anaeropharma Science was established in 2004 to pioneer the development of novel therapeutics to target such a hypoxic environment in solid cancers based on its proprietary platform technology, recombinant bifidobacterium therapeutics.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.